1921
Volume 71, Issue 5_suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Preview this article:
Zoom in
Zoomout

2.3 LF DISEASE—CLINICAL MANAGEMENT, Page 1 of 1

| /docserver/preview/fulltext/14761645/71/5_suppl/0700012-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2004.71.5_suppl.0700012
2004-11-01
2017-11-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/71/5_suppl/0700012.html?itemId=/content/journals/10.4269/ajtmh.2004.71.5_suppl.0700012&mimeType=html&fmt=ahah

References

  1. Seim A, Dreyer G, Addis D, 1999. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Rev Soc Bras Med Trop 32: 325–328.
  2. Fan PC, Peng HW, Chen CC, 1995. Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kihmen (Quemoy) Island, Republic of China. Am J Trop Med Hyg 98: 461–464.
  3. Suma TK, Shenoy RK, Kumaraswami V, 2002. Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis. Trop Med Int Health 7: 763–766.
  4. Shenoy RK, Suma TK, Rajan K, Kumaraswami V, 1998. Prevention of acute adenolymphangitis in Brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol 92: 587–594.
  5. McPherson T, 2003. Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: a preliminary clinical intervention study. Filaria J 2: 1.
  6. Coreil J, Mayard G, Addis D, 2002. Benefits of support groups in the management of filariasis. TDR Final Report Series, No. 56, Lymphatic Filariasis. Geneva: World Health Organization.
  7. Dreyer G, Addiss D, Noroes J, 2002. Basic Lympheodema Management: Treatment and Prevention of Problems Associated with Lymphatic Filariasis. Hollis, NH: Hollis Publishing Co.
  8. Molyneux DH, Zagaria N, 2002. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 96 (Suppl 2): S15–S40.
  9. Vaqas B, Ryan TJ, 2003. Lymphedema: pathophysiology and management in resource-poor settings—relevance for lymphatic filariasis control programmes. Filarial J 2: 4.
  10. El Setouhy M, Ramzy RMR, Ahmed ES, Kandil AM, Hussain O, Farid HA, Helmy H, Weil GJ, 2003. A randomized clinical trial comparing single and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of Bancroftian filariasis. Am J Trop Med Hyg 70: 191–196.
  11. Dreyer G, Pires ML, Andrade LD, Lopes E, Medeiros Z, Tenorio J, Coutinho A, Noroes J, Figueredo-Silva J, 1994. Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of bancroftian filariasis, Recife, Brazil. Trans R Soc Trop Med Hyg 88: 232–236.
  12. Dreyer G, Addiss D, Noroes J, Amaral F, Rocha A, Coutinho A, 1996. Direct assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian Filariasis. Trop Med Int Health 1: 427–432.
  13. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW, 2002. Mass treatment to eliminate filariasis in Papua New Guinea, N Engl J Med 347: 1841–1848.
  14. Dreyer G, Noroes J, Figueredo-Silva J, Piessens, WF, 2002. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 16: 544–548.
  15. Dreyer G, Medeiros Z, Netto MJ, Leal NC, de Castro LG, Piessens WF, 1999. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg 93: 413–417.
  16. Taylor MJ, 2003. Wolbachia in the inflammatory pathogenesis of human filariasis. Ann N Y Acad Sci 990: 444–449.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2004.71.5_suppl.0700012
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error